Advanced search
Publication Cover
Cancer Investigation Volume 21, 2003 - Issue 2
Submit an article Journal homepage
592
Views
93
CrossRef citations to date
0
Altmetric
Original

Phase II Trial Of Pegylated-liposomal Doxorubicin (Doxil™) In Sarcoma*

ORIGINAL ARTICLE

Keith M. Skubitz M.D. University of Minnesota Medical School and Masonic Cancer Center, Minneapolis, MinnesotaUSA; University Hospital, Box 286, Minneapolis, Minnesota, 55455, USA
Pages 167-176 | Published online: 25 Mar 2003

Citations (93)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (9)

Marite Skrinda-Melne, Janis Locs, Andra Grava & Arita Dubnika. (2023) Calcium phosphates enhanced with liposomes – the future of bone regeneration and drug delivery. Journal of Liposome Research 0:0, pages 1-16.
Read now
Lee D Cranmer. (2019) Spotlight on aldoxorubicin (INNO-206) and its potential in the treatment of soft tissue sarcomas: evidence to date. OncoTargets and Therapy 12, pages 2047-2062.
Read now
Jun Gong, Jessica Yan, Charles Forscher & Andrew Hendifar. (2018) Aldoxorubicin: a tumor-targeted doxorubicin conjugate for relapsed or refractory soft tissue sarcomas. Drug Design, Development and Therapy 12, pages 777-786.
Read now
Xin-Yi Lu, Song Hu, Yi Jin & Li-Yan Qiu. (2012) Application of liposome encapsulation technique to improve anti-carcinoma effect of resveratrol. Drug Development and Industrial Pharmacy 38:3, pages 314-322.
Read now
Dae-Geun Jeon & Won Seok Song. (2010) How can survival be improved in localized osteosarcoma?. Expert Review of Anticancer Therapy 10:8, pages 1313-1325.
Read now
Rashmi Chugh & Laurence H Baker. (2009) Pharmacotherapy of sarcoma. Expert Opinion on Pharmacotherapy 10:12, pages 1953-1963.
Read now
Kathleen O’Day & Richard Gorlick. (2009) Novel therapeutic agents for osteosarcoma. Expert Review of Anticancer Therapy 9:4, pages 511-523.
Read now
Vladimir Torchilin. (2008) Antibody-modified liposomes for cancer chemotherapy. Expert Opinion on Drug Delivery 5:9, pages 1003-1025.
Read now
. (2003) Literature Alerts. Journal of Microencapsulation 20:6, pages 817-824.
Read now

Articles from other publishers (84)

Angela Buonadonna, Simona Scalone, Davide Lombardi, Arianna Fumagalli, Alessandra Guglielmi, Chiara Lestuzzi, Jerry Polesel, Vincenzo Canzonieri, Stefano Lamon, Petros Giovanis, Sara Gagno, Giuseppe Corona, Maurizio Mascarin, Claudio Belluco, Antonino De Paoli, Gianpiero Fasola, Fabio Puglisi & Gianmaria Miolo. (2023) Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas. Cancers 15:20, pages 5036.
Crossref
Xiaoyang Song, Yongjie Qiao, Haoqiang Zhang, Lirong Sha, Jinpeng Lou, Xinyuan Yu, Hao Liu, Langfeng Zhu & Shenghu Zhou. (2023) Malignant transformation of an aneurysmal bone cyst of the femoral neck: A case report. Experimental and Therapeutic Medicine 26:2.
Crossref
Jessica Ngai, Presley MacMillan, Benjamin R. Kingston, Zachary P. Lin, Ben Ouyang & Warren C.W. Chan. (2023) Delineating the tumour microenvironment response to a lipid nanoparticle formulation. Journal of Controlled Release 353, pages 988-1001.
Crossref
Sijia Zhang, Leichong Chen, Yan Zong, Qianwen Li, Kuikui Zhu, Zhenyu Li & Rui Meng. (2022) Research progress of tumor‐derived extracellular vesicles in the treatment of malignant pleural effusion. Cancer Medicine 12:2, pages 983-994.
Crossref
Raghavendra C. Mundargi, Neetika Taneja, Jayeshkumar J. Hadia & Ajay J. Khopade. 2022. Targeted Drug Delivery. Targeted Drug Delivery 69 125 .
Elidamar Nunes de Carvalho Lima, Guilherme Leão Barros Martins, Ricardo Sobhie Diaz, Mauro Schechter, José Roberto Castilho Piqueira & João Francisco Justo. (2022) Effects of Carbon Nanomaterials and Aloe vera on Melanomas—Where Are We? Recent Updates. Pharmaceutics 14:10, pages 2004.
Crossref
Peng Lin, Yucheng Xue, Xueluer Mu, Youyou Shao, Qian Lu, Xiangang Jin, Eloy Yinwang, Zengjie Zhang, Hao Zhou, Wangsiyuan Teng, Hangxiang Sun, Weida Chen, Wei Shi, Cangyi Shi, Xianfeng Zhou, Xuesheng Jiang, Xiaohua Yu & Zhaoming Ye. (2022) Tumor Customized 2D Supramolecular Nanodiscs for Ultralong Tumor Retention and Precise Photothermal Therapy of Highly Heterogeneous Cancers. Small 18:21, pages 2200179.
Crossref
Xi-zhi Wen, Qiu-zhong Pan, Bu-shu Xu, Wei Xiao, De-sheng Weng, Jing-jing Zhao, Hai-rong Xu, Zhen Huang, Xiao-hui Niu & Xing Zhang. (2022) Phase I study of pegylated liposomal doxorubicin and cisplatin in patients with advanced osteosarcoma. Cancer Chemotherapy and Pharmacology 89:2, pages 209-215.
Crossref
Prateek Srivastava, Sumit Kumar Hira & Partha Pratim Manna. 2022. 2D Nanomaterials for Energy and Environmental Sustainability. 2D Nanomaterials for Energy and Environmental Sustainability 197 221 .
Claudia Maria Hattinger, Maria Pia Patrizio, Leonardo Fantoni, Chiara Casotti, Chiara Riganti & Massimo Serra. (2021) Drug Resistance in Osteosarcoma: Emerging Biomarkers, Therapeutic Targets and Treatment Strategies. Cancers 13:12, pages 2878.
Crossref
Subhasis Roy, Prasenjit Mukherjee, Pradip Kumar Das, Prabal Ranjan Ghosh, Pradyot Datta, Biswanath Kundu & Samit Kumar Nandi. (2021) Local delivery systems of morphogens/biomolecules in orthopedic surgical challenges. Materials Today Communications 27, pages 102424.
Crossref
Jing Liu, Xiang Li, Lina Liu, Qiang Bai, Ning Sui & Zhiling Zhu. (2021) Self-assembled ultrasmall silver nanoclusters on liposome for topical antimicrobial delivery. Colloids and Surfaces B: Biointerfaces 200, pages 111618.
Crossref
Duopeng An, Xiaochen Yu, Lijing Jiang, Rui Wang, Peng He, Nanye Chen, Xiaohan Guo, Xiang Li & Meiqing Feng. (2021) Reversal of Multidrug Resistance by Apolipoprotein A1-Modified Doxorubicin Liposome for Breast Cancer Treatment. Molecules 26:5, pages 1280.
Crossref
Jianping Hu, Yingying Jiang, Shuo Tan, Kunpeng Zhu, Tao Cai, Taicheng Zhan, Shisheng He, Feng Chen & Chunlin Zhang. (2021) Selenium-doped calcium phosphate biomineral reverses multidrug resistance to enhance bone tumor chemotherapy. Nanomedicine: Nanotechnology, Biology and Medicine 32, pages 102322.
Crossref
Fahad A. Almughem, Abdullah A. Alshehri & Mohammad N. Alomary. 2021. Role of Exosomes in Biological Communication Systems. Role of Exosomes in Biological Communication Systems 337 360 .
Ieva Palubeckaitė, Sanne Venneker, Inge H. Briaire-de Bruijn, Brendy E. van den Akker, Augustinus D. Krol, Hans Gelderblom & Judith V. M. G. Bovée. (2020) Selection of Effective Therapies Using Three-Dimensional in vitro Modeling of Chondrosarcoma. Frontiers in Molecular Biosciences 7.
Crossref
Dong Hyun Kim, Han Sol Lee, Yong-Hyeon Mun, SeokJin Koh, Joon-Sun Park, Sang Min Lee, Nae-Won Kang, Mee Yeon Lee, Cheong-Weon Cho, Dae-Duk Kim & Jae-Young Lee. (2020) An overview of chondrosarcoma with a focus on nanoscale therapeutics. Journal of Pharmaceutical Investigation 50:6, pages 537-552.
Crossref
Caitlin Tydings & AeRang Kim. (2020) Technology and precision therapy delivery in childhood cancer. Current Opinion in Pediatrics 32:1, pages 1-6.
Crossref
Caitlin Tydings, Karun V. Sharma, AeRang Kim & Pavel S. Yarmolenko. (2020) Emerging hyperthermia applications for pediatric oncology. Advanced Drug Delivery Reviews 163-164, pages 157-167.
Crossref
Brian A. Van Tine. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1655 1693.e11 .
Malvi Savani, Paari Murugan & Keith M. Skubitz. (2019) Long-term cure of soft tissue sarcoma with pegylated-liposomal doxorubicin after doxorubicin and ifosfamide failure. Clinical Sarcoma Research 9:1.
Crossref
Elena Gazzano, Ilaria Buondonno, Alessandro Marengo, Barbara Rolando, Konstantin Chegaev, Joanna Kopecka, Simona Saponara, Matteo Sorge, Claudia Maria Hattinger, Alberto Gasco, Roberta Fruttero, Mara Brancaccio, Massimo Serra, Barbara Stella, Elias Fattal, Silvia Arpicco & Chiara Riganti. (2019) Hyaluronated liposomes containing H2S-releasing doxorubicin are effective against P-glycoprotein-positive/doxorubicin-resistant osteosarcoma cells and xenografts. Cancer Letters 456, pages 29-39.
Crossref
Daniel F. Pease, Bruce A. Peterson, Scott Gilles, Maria K. Hordinsky, Kimberly A. Bohjanen & Keith M. Skubitz. (2019) Development of cutaneous squamous cell carcinoma after prolonged exposure to pegylated liposomal doxorubicin and hand–foot syndrome: a newly recognized toxicity. Cancer Chemotherapy and Pharmacology 84:1, pages 217-221.
Crossref
Keith M. Skubitz, Anne H. Blaes, Suma H. Konety & Gary S. Francis. (2017) Cardiac safety profile of patients receiving high cumulative doses of pegylated-liposomal doxorubicin: use of left ventricular ejection fraction is of unproven value. Cancer Chemotherapy and Pharmacology 80:4, pages 787-798.
Crossref
Gino K. In, James S. Hu & William W. Tseng. (2017) Treatment of advanced, metastatic soft tissue sarcoma: latest evidence and clinical considerations. Therapeutic Advances in Medical Oncology 9:8, pages 533-550.
Crossref
Mehmet Besiroglu, Faysal Dane, Aydin Ciltas & Mustafa Benekli. (2017) Systemic chemotherapy of advanced soft tissue sarcomas. Journal of Oncological Sciences 3:2, pages 66-70.
Crossref
Claudia M Hattinger, Marilù Fanelli, Elisa Tavanti, Serena Vella, Chiara Riganti, Piero Picci & Massimo Serra. (2017) Doxorubicin-resistant osteosarcoma: novel therapeutic approaches in sight?. Future Oncology 13:8, pages 673-677.
Crossref
Alexander T. J. Lee, Seth M. Pollack, Paul Huang & Robin L. Jones. (2017) Phase III Soft Tissue Sarcoma Trials: Success or Failure?. Current Treatment Options in Oncology 18:3.
Crossref
Dennis A. Priebat. 2017. Sarcoma. Sarcoma 223 255 .
Mariacristina Gagliardi. (2016) Novel biodegradable nanocarriers for enhanced drug delivery. Therapeutic Delivery 7:12, pages 809-826.
Crossref
Sumati Gupta, Launce Gouw, Jennifer Wright, Sant Chawla, Debbie Pitt, Mark Wade, Ken Boucher & Sunil Sharma. (2016) Phase II study of amrubicin (SM-5887), a synthetic 9-aminoanthracycline, as first line treatment in patients with metastatic or unresectable soft tissue sarcoma: durable response in myxoid liposarcoma with TLS-CHOP translocation. Investigational New Drugs 34:2, pages 243-252.
Crossref
Seung Han Shin, Young Joon Choi, Hyewon Lee, Han-Soo Kim & Sung Wook Seo. (2015) Oxidative stress induced by low-dose doxorubicin promotes the invasiveness of osteosarcoma cell line U2OS in vitro. Tumor Biology 37:2, pages 1591-1598.
Crossref
Marco Mazzotta, Raffaele Giusti, Daniela Iacono, Salvatore Lauro & Paolo Marchetti. (2016) Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous Angiosarcoma. Case Reports in Oncological Medicine 2016, pages 1-5.
Crossref
Ke Ren, Xin Wei, Lingli Zhang & Dong Wang. 2016. Nanomaterials in Pharmacology. Nanomaterials in Pharmacology 389 412 .
Joanne Lagmay & Nicholas D. Yeager. 2015. Malignant Pediatric Bone Tumors - Treatment & Management. Malignant Pediatric Bone Tumors - Treatment & Management 221 263 .
Annemiek M van Maldegem, Judith VMG Bovée & Hans Gelderblom. (2014) Comprehensive analysis of published studies involving systemic treatment for chondrosarcoma of bone between 2000 and 2013. Clinical Sarcoma Research 4:1.
Crossref
Charlene M. Dawidczyk, Chloe Kim, Jea Ho Park, Luisa M. Russell, Kwan Hyi Lee, Martin G. Pomper & Peter C. Searson. (2014) State-of-the-art in design rules for drug delivery platforms: Lessons learned from FDA-approved nanomedicines. Journal of Controlled Release 187, pages 133-144.
Crossref
Jie Zheng, Yu Wan, Abdelbary Elhissi, Zhirong Zhang & Xun Sun. (2014) Targeted Paclitaxel Delivery to Tumors Using Cleavable PEG-Conjugated Solid Lipid Nanoparticles. Pharmaceutical Research 31:8, pages 2220-2233.
Crossref
Shyamal Kumar Kundu, Ashish Ranjan Sharma, Sang-Soo Lee, Garima Sharma, C. George Priya Doss, Shin Yagihara, Do-Young Kim, Ju-Suk Nam & Chiranjib Chakraborty. (2014) Recent Trends of Polymer Mediated Liposomal Gene Delivery System. BioMed Research International 2014, pages 1-15.
Crossref
Lee J. Helman & Robert G. Maki. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology 1753 1791.e10 .
Sheetal Sharma, Shweta Takyar, Stephanie C Manson, Sarah Powell & Nicolas Penel. (2013) Efficacy and safety of pharmacological interventions in second- or later-line treatment of patients with advanced soft tissue sarcoma: a systematic review. BMC Cancer 13:1.
Crossref
Ruenn Chai Lai, Ronne Wee Yeh Yeo, Kok Hian Tan & Sai Kiang Lim. (2013) Exosomes for drug delivery ? a novel application for the mesenchymal stem cell. Biotechnology Advances 31:5, pages 543-551.
Crossref
Emily M. Curtis & Carol K. Hall. (2013) Molecular Dynamics Simulations of DPPC Bilayers Using “LIME”, a New Coarse-Grained Model. The Journal of Physical Chemistry B 117:17, pages 5019-5030.
Crossref
Alexander J. Chou, Renu Gupta, Moshe D. Bell, Kathleen O'Day Riewe, Paul A. Meyers & Richard Gorlick. (2012) Inhaled lipid cisplatin (ILC) in the treatment of patients with relapsed/progressive osteosarcoma metastatic to the lung. Pediatric Blood & Cancer 60:4, pages 580-586.
Crossref
Ronne Wee Yeh Yeo, Ruenn Chai Lai, Bin Zhang, Soon Sim Tan, Yijun Yin, Bao Ju Teh & Sai Kiang Lim. (2013) Mesenchymal stem cell: An efficient mass producer of exosomes for drug delivery. Advanced Drug Delivery Reviews 65:3, pages 336-341.
Crossref
Shalu Suri, Gang Ruan, Jessica Winter & Christine E. Schmidt. 2013. Biomaterials Science. Biomaterials Science 360 388 .
Chiara Lestuzzi, Gianmaria Miolo & Antonino De Paoli. 2013. Cardiac Tumor Pathology. Cardiac Tumor Pathology 165 182 .
Katarzyna Rudzka, Ángel V. Delgado & Julián L. Viota. (2012) Maghemite Functionalization for Antitumor Drug Vehiculization. Molecular Pharmaceutics 9:7, pages 2017-2028.
Crossref
Pengxiang Zhao & Didier Astruc. (2012) Docetaxel Nanotechnology in Anticancer Therapy. ChemMedChem 7:6, pages 952-972.
Crossref
Richard F. Riedel. (2011) Systemic therapy for advanced soft tissue sarcomas. Cancer 118:6, pages 1474-1485.
Crossref
Warefta Hasan, Kevin Chu, Anuradha Gullapalli, Stuart S. Dunn, Elizabeth M. Enlow, J. Christopher Luft, Shaomin Tian, Mary E. Napier, Patrick D. Pohlhaus, Jason P. Rolland & Joseph M. DeSimone. (2011) Delivery of Multiple siRNAs Using Lipid-Coated PLGA Nanoparticles for Treatment of Prostate Cancer. Nano Letters 12:1, pages 287-292.
Crossref
Vladimir Torchilin. 2012. Fundamentals and Applications of Controlled Release Drug Delivery. Fundamentals and Applications of Controlled Release Drug Delivery 289 328 .
Sujana Movva & Claire Verschraegen. (2011) Systemic Management Strategies for Metastatic Soft Tissue Sarcoma. Drugs 71:16, pages 2115-2129.
Crossref
Vladimir P. Torchilin. 2011. Drug Delivery in Oncology. Drug Delivery in Oncology 951 987 .
Sherif S. Morgan & Lee D. Cranmer. (2011) Systematic Therapy for Unresectable or Metastatic Soft-Tissue Sarcomas: Past, Present, and Future. Current Oncology Reports 13:4, pages 331-349.
Crossref
Vladimir Torchilin. (2011) Tumor delivery of macromolecular drugs based on the EPR effect. Advanced Drug Delivery Reviews 63:3, pages 131-135.
Crossref
Vladimir P. Torchilin. 2010. Drug Delivery. Drug Delivery 3 53 .
Rosanna Ricafort & Richard Gorlick. 2010. Molecularly Targeted Therapy for Childhood Cancer. Molecularly Targeted Therapy for Childhood Cancer 459 498 .
Iuliana Shapira, Daniel R. Budman, Thomas Bradley & Richard Gralla. (2009) Evolving lipid-based delivery systems in the management of neoplastic disease. Oncology Reviews 3:2, pages 113-124.
Crossref
Tamer A. ElBayoumi & Vladimir P. Torchilin. (2008) Tumor-Specific Anti-Nucleosome Antibody Improves Therapeutic Efficacy of Doxorubicin-Loaded Long-Circulating Liposomes against Primary and Metastatic Tumor in Mice. Molecular Pharmaceutics 6:1, pages 246-254.
Crossref
Tal Grenader, Anthony Goldberg, Irit Hadas-Halperin & Alberto Gabizon. (2009) Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomas. Anti-Cancer Drugs 20:1, pages 15-20.
Crossref
Pete Anderson. 2010. Pediatric and Adolescent Osteosarcoma. Pediatric and Adolescent Osteosarcoma 203 215 .
Katherine Thornton & Robert Benjamin. 2008. Comprehensive Management of Skull Base Tumors. Comprehensive Management of Skull Base Tumors 473 480 .
M. von Mehren, R.J. Schilder, J.D. Cheng, E. Temmer, T.M. Cardoso, F.G. Renshaw, E. Bayever, P. Zannikos, Z. Yuan & R.B. Cohen. (2008) A phase I study of the safety and pharmacokinetics of trabectedin in combination with pegylated liposomal doxorubicin in patients with advanced malignancies. Annals of Oncology 19:10, pages 1802-1809.
Crossref
Liangfang Zhang, Juliana M. Chan, Frank X. Gu, June-Wha Rhee, Andrew Z. Wang, Aleksandar F. Radovic-Moreno, Frank Alexis, Robert Langer & Omid C. Farokhzad. (2008) Self-Assembled Lipid−Polymer Hybrid Nanoparticles: A Robust Drug Delivery Platform. ACS Nano 2:8, pages 1696-1702.
Crossref
Katherine Thornton, Catherine E. Pesce & Michael A. Choti. (2008) Multidisciplinary Management of Metastatic Sarcoma. Surgical Clinics of North America 88:3, pages 661-672.
Crossref
Katherine Thornton. (2008) Chemotherapeutic Management of Soft Tissue Sarcoma. Surgical Clinics of North America 88:3, pages 647-660.
Crossref
Keith M Skubitz & Js Carlos Manivel. (2007) Giant cell tumor of the uterus: case report and response to chemotherapy. BMC Cancer 7:1.
Crossref
Keith M. Skubitz & David R. D'Adamo. (2007) Sarcoma. Mayo Clinic Proceedings 82:11, pages 1409-1432.
Crossref
Vladimir P. Torchilin. (2007) Targeted pharmaceutical nanocarriers for cancer therapy and imaging. The AAPS Journal 9:2, pages E128-E147.
Crossref
Miriam M. Kleiter, Daohai Yu, Lenore A. Mohammadian, Nelsen Niehaus, Ivan Spasojevic, Linda Sanders, Benjamin L. Viglianti, Pavel S. Yarmolenko, Marlene Hauck, Neil A. Petry, Terence Z. Wong, Mark W. Dewhirst & Donald E. Thrall. (2006) A Tracer Dose of Technetium-99m–Labeled Liposomes Can Estimate the Effect of Hyperthermia on Intratumoral Doxil Extravasation. Clinical Cancer Research 12:22, pages 6800-6807.
Crossref
Peter Laverman, Gert Storm, William Phillips, Ande Bao & Beth Goins. 2006. Liposome Technology, Volume II. Liposome Technology, Volume II 169 185 .
O.S. Nielsen, P. Reichardt, T.B. Christensen, D. Pink, S. Daugaard, C. Hermans, S. Marreaud, M. van Glabbeke, J. Blay & I. Judson. (2006) Phase 1 European Organisation for Research and Treatment of Cancer study determining safety of pegylated liposomal doxorubicin (Caelyx®) in combination with ifosfamide in previously untreated adult patients with advanced or metastatic soft tissue sarcomas. European Journal of Cancer 42:14, pages 2303-2309.
Crossref
Amalia Milano, Gaetano Apice, Ettore Ferrari, Flavio Fazioli, Vincenzo de Rosa, Antonella Salzano de Luna, Rosario Vincenzo Iaffaioli & Francesco Caponigro. (2006) New emerging drugs in soft tissue sarcoma. Critical Reviews in Oncology/Hematology 59:1, pages 74-84.
Crossref
Dhatri Kodali & Kala Seetharaman. (2006) Primary Cardiac Angiosarcoma. Sarcoma 2006, pages 1-3.
Crossref
Randy N. Rosier & Susan V. Bukata. 2006. Oncology. Oncology 1034 1047 .
Jan M. Siehl, Eckhard Thiel, Alexander Schmittel, Gero Hütter, Peter M. Deckert, Hubert Szelényi & Ulrich Keilholz. (2005) Ifosfamide/liposomal daunorubicin is a well tolerated and active first‐line chemotherapy regimen in advanced soft tissue sarcoma. Cancer 104:3, pages 611-617.
Crossref
Keith M. Skubitz & Philip A. Haddad. (2005) Paclitaxel and pegylated‐liposomal doxorubicin are both active in angiosarcoma. Cancer 104:2, pages 361-366.
Crossref
Vladimir P. Torchilin. (2005) Recent advances with liposomes as pharmaceutical carriers. Nature Reviews Drug Discovery 4:2, pages 145-160.
Crossref
Jorge Casas-Ganem & John H Healey. (2005) Advances that are changing the diagnosis and treatment of malignant bone tumors. Current Opinion in Rheumatology 17:1, pages 79-85.
Crossref
A. Poveda, A. López-Pousa, J. Martín, J. García Del Muro, R. Bernabé, A. Casado, C. Balañá, O. Sanmartín, M. D. Menéndez, P. Escudero, J. Cruz, Elena Belyakova, D. Menéndez & J. M. Buesa. (2005) Phase II Clinical Trial With Pegylated Liposomal Doxorubicin (CAELYX®/Doxil®) and Quality of Life Evaluation (EORTC QLQ-C30) in Adult Patients With Advanced Soft Tissue Sarcomas: A study of the Spanish Group for Research in Sarcomas (GEIS). Sarcoma 9:3-4, pages 127-132.
Crossref
David S. Alberts, Franco M. Muggia, James Carmichael, Eric P. Winer, Mohammad Jahanzeb, Alan P. Venook, Keith M. Skubitz, Edgardo Rivera, Joseph A. Sparano, Nicholas J. Dibella, Simon J. Stewart, John J. Kavanagh & Alberto A. Gabizon. (2004) Efficacy and safety of liposomal anthracyclines in Phase I/II clinical trials. Seminars in Oncology 31, pages 53-90.
Crossref
Anatoly N. Lukyanov, Tamer A. Elbayoumi, Ananthsrinivas R. Chakilam & Vladimir P. Torchilin. (2004) Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody. Journal of Controlled Release 100:1, pages 135-144.
Crossref
Ande Bao, Beth Goins, Robert Klipper, George Negrete & William T. Phillips. (2004) Direct 99m Tc Labeling of Pegylated Liposomal Doxorubicin (Doxil) for Pharmacokinetic and Non-Invasive Imaging Studies . Journal of Pharmacology and Experimental Therapeutics 308:2, pages 419-425.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.